DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 104 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,082,000 | -44.5% | 152,900 | +2.7% | 0.00% | -33.3% |
| Q2 2021 | $5,557,000 | +49.1% | 148,900 | +2.2% | 0.00% | +50.0% |
| Q1 2021 | $3,726,000 | +18.2% | 145,700 | +1.8% | 0.00% | 0.0% |
| Q4 2020 | $3,152,000 | +23.0% | 143,100 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $2,562,000 | -27.9% | 142,400 | +1.8% | 0.00% | -33.3% |
| Q2 2020 | $3,553,000 | +94.4% | 139,900 | +40.6% | 0.00% | +50.0% |
| Q1 2020 | $1,828,000 | -15.4% | 99,500 | +1.4% | 0.00% | 0.0% |
| Q4 2019 | $2,161,000 | +56.5% | 98,100 | +2.0% | 0.00% | +100.0% |
| Q3 2019 | $1,381,000 | +0.1% | 96,200 | +9.8% | 0.00% | 0.0% |
| Q2 2019 | $1,380,000 | +17.7% | 87,600 | +9.5% | 0.00% | 0.0% |
| Q1 2019 | $1,172,000 | +45.2% | 80,000 | +6.0% | 0.00% | 0.0% |
| Q4 2018 | $807,000 | -19.3% | 75,500 | +15.3% | 0.00% | 0.0% |
| Q3 2018 | $1,000,000 | +50.8% | 65,500 | +21.1% | 0.00% | 0.0% |
| Q2 2018 | $663,000 | – | 54,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
| Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
| RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
| EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
| BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
| DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
| Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
| Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |